history control tooltip
divider handle tooltip
Irritable bowel syndrome in adults
Short Text
Introduction
This pathway covers the diagnosis and management of irritable bowel syndrome in primary care.
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, with a prevalence estimated at between 10% and 20%. People present to primary care with a wide range of symptoms, some of which overlap with other gastrointestinal disorders.
Key elements of management are:
- establishing a positive diagnosis
- identifying symptoms that require prompt referral and
- working in a long-term partnership with the person with irritable bowel syndrome.
Source guidance
The NICE guidance that was used to create the pathway.
Irritable bowel syndrome in adults. NICE clinical guideline 61 (2008)
Quality standards
Quality statements
Effective interventions library
Successful effective interventions library details
Implementation
Audit support
Audit support provides ready-to-use criteria, including exceptions, definitions, suggested data sources and a data collection tool.
Costing support
Costing support includes national cost impact reports that summarise the national costs and savings and discuss the assumptions used; costing templates to assess the impact on local budgets; and costing statements when the impact is not significant or impossible to quantify at a national level.
Education tools
NICE has developed online learning modules, in collaboration with a range of providers, including BMJ Learning, to update knowledge on evidence and NICE guidance.
Information resources and templates
These include key points for scrutiny or compliance assessment, signposting to resources, checklists and case studies. They are designed to offer practical help in putting NICE guidance into practice and the format depends on the specific topic.
Slide sets
Slide sets provide a framework for discussion and assist in local dissemination of the guidance. The slides contain the key messages from NICE guidance and can be tailored for local presentations.
Pathway information
Important information about diagnosing irritable bowel syndrome
Confirming a diagnosis of irritable bowel syndrome is crucial. The primary aim should be to establish the person's symptom profile, with abdominal pain or discomfort being a key symptom. It is also necessary to establish the quantity and quality of the pain or discomfort, and to identify its site (which can be anywhere in the abdomen) and whether this varies. This distinguishes irritable bowel syndrome from cancer-related pain, which typically has a fixed site.
When establishing bowel habit, showing people the Bristol stool form scale may help them with description, particularly when determining quality and quantity of stool. People presenting with irritable bowel syndrome symptoms commonly report incomplete evacuation/rectal hypersensitivity, as well as urgency, which is increased in diarrhoea-predominant irritable bowel syndrome. About 20% of people experiencing faecal incontinence disclose their incontinence only if asked. People who present with symptoms of irritable bowel syndrome should be asked open questions to establish the presence of such symptoms (for example, 'tell me about how your symptoms affect aspects of your daily life, such as leaving the house'). Healthcare professionals should be sensitive to the cultural, ethnic and communication needs of people for whom English is not a first language or who may have cognitive and/or behavioural problems or disabilities. These factors should be taken into consideration to facilitate effective consultation.
Information for the public
NICE produces information for the public that summarises, in plain English, the recommendations that NICE makes to healthcare and other professionals.
NICE has written information for the public explaining its guidance on irritable bowel syndrome.
Patient-centred care
Patients and healthcare professionals have rights and responsibilities as set out in the NHS Constitution for England – all NICE guidance is written to reflect these. Treatment and care should take into account individual needs and preferences. People should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. If someone does not have the capacity to make decisions, healthcare professionals should follow the Department of Health's advice on consent, the code of practice that accompanies the Mental Capacity Act and the supplementary code of practice on deprivation of liberty safeguards. In Wales, healthcare professionals should follow advice on consent from the Welsh Government.
If the person is under 16, healthcare professionals should follow the guidelines in Seeking consent: working with children. If a young person is moving between paediatric and adult services their care should be planned and managed according to the best practice guidance described in the Department of Health's Transition: getting it right for young people.
Updates to this pathway
19 October 2012 Minor maintenance update.
Supporting information
Glossary
Cognitive behavioural therapy
C-reactive protein
Endomysial antibodies
Erythrocyte sedimentation rate
Full blood count
Selective serotonin reuptake inhibitor
Tricyclic antidepressant
Tissue transglutaminase
Person reporting any of the following symptoms for at least 6 months: abdominal pain or discomfort, bloating, or a change in bowel habit
Person reporting any of the following symptoms for at least 6 months:
- Abdominal pain or discomfort
- Bloating
- Change in bowel habit
Looking for 'red flag' indicators for referral to secondary care
Looking for 'red flag' indicators for referral to secondary care
Looking for 'red flag' indicators for referral to secondary care
Ask all people with possible irritable bowel syndrome symptoms if they have any of the following 'red flag' indicators and refer them to secondary care for further investigation if they have.
- Unintentional and unexplained weight loss.
- Rectal bleeding.
- A family history of bowel or ovarian cancer.
- In people aged over 60, a change in bowel habit lasting more than 6 weeks with looser and/or more frequent stools.
Assess and clinically examine all people with possible irritable bowel syndrome symptoms and refer to secondary care if any of the following 'red flags' are found:
- anaemia
- abdominal masses
- rectal masses
- inflammatory markers for inflammatory bowel disease.
Measure serum CA125 in primary care in women with symptoms that suggest ovarian cancer in line with NICE's pathway on ovarian cancer.
See referral guidelines for suspected cancer (NICE clinical guideline 27) for detailed referral criteria where cancer is suspected.
NICE has also produced a pathway on colorectal cancer.
Source guidance
Failed to load fragment (default behaviour with no loader supplied): staticcontentfragments/source-guidance-nodeDiagnosing irritable bowel syndrome
View the 'Diagnosing irritable bowel syndrome' pathFollow-up
Follow-up
Follow-up
Agree follow-up with the person based on symptom responses to interventions. This should form part of the annual patient review.
Investigate or refer to secondary care if 'red flag' symptoms appear during management and follow-up.
For more information about 'red flag' symptoms, see looking for 'red flag' indicators for referral to secondary care in this pathway.
Source guidance
Failed to load fragment (default behaviour with no loader supplied): staticcontentfragments/source-guidance-nodeReferral for psychological interventions
Referral for psychological interventions
Referral for psychological interventions
For people whose symptoms do not respond to pharmacological treatments after 12 months and who develop a continuing symptom profile (refractory irritable bowel syndrome), consider referring for:
- CBT
- hypnotherapy
- psychological therapy.
Source guidance
Failed to load fragment (default behaviour with no loader supplied): staticcontentfragments/source-guidance-nodePaths in this pathway
Pathway created: October 2012 Last updated: October 2012
Copyright © 2013 National Institute for Health and Care Excellence. All Rights Reserved.